Condition
Reflux Disease
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed4
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06129474Not ApplicableRecruiting
Deprescribing Inappropriate Proton Pump Inhibitors
NCT05051475Not ApplicableCompleted
Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus
NCT06381583Completed
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
NCT05634187CompletedPrimary
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
NCT05004155Unknown
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
NCT00757419Phase 1CompletedPrimary
AZD3355 Dose-escalation Study in Healthy Males
Showing all 6 trials